山东绿叶制药有限公司 Lvye
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China 2021-05-26 23:03
Luye Pharma's Innovative Alzheimer's Disease Therapy Rivastigmine Multi-Day Transdermal Patch Now Eligible for Marketing Authorization in Several EU Countries 2021-05-24 10:27
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021 2021-05-14 11:58
GeneLeap Presents New Preclinical Data for Hydrogel Encapsulated TLR9 Agonist at AACR 2021 2021-04-14 14:54
Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration to Develop and Commercialize Rivastigmine Multi-Day Transdermal Patch in Japan 2021-02-18 11:24
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness 2020-11-26 16:44
Over One Thousand Psychiatrists Gather Online for Second Asia Pacific Psychiatry Symposium 2020-10-19 17:46
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR® 2020-06-01 15:22
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities 2020-05-20 19:34
Luye Pharma Continues to Deliver Strong Growth in 2019 2020-03-27 16:44
NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA 2020-03-04 21:27
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries 2020-02-11 08:51
Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation 2019-11-05 00:39
The First Asia Pacific Psychiatry Symposium Takes Place 2019-09-03 13:11
The First Asia Pacific Psychiatry Symposium Takes Place 2019-09-03 12:44
Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines 2019-08-29 16:34
Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Extended Release Tablets to Start Clinical Trials in Japan 2019-08-22 15:36
Luye Pharma's Rykindo® NDA Filing Accepted by the U.S. FDA 2019-05-30 13:09
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval 2019-03-29 11:48
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field 2019-01-16 19:08
1 2 3